Atrial fibrillation: An old disease, a new epidemic

American Journal of Medicine

Volumn 113, Issue 5, 2002, Pages 432-435

  Tsang, Teresa S M ^a   Gersh, Bernard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; TUMOR NECROSIS FACTOR;

AGE; AGED; ALCOHOL CONSUMPTION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEMOGRAPHY; EDITORIAL; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEMODYNAMICS; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; LUNG DISEASE; MALE; MORBIDITY; MORTALITY; OBESITY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE; THROMBOCYTE FUNCTION; THYROID DISEASE; UNITED STATES; VALVULAR HEART DISEASE;

ATRIAL FIBRILLATION; DISEASE OUTBREAKS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL RATE;

EID: 0036797776     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01245-7     Document Type: Editorial

References (49)

1. Braunwald E. Shattuck lecture. Cardiovascular medicine at the turn of the millennium triumphs, concerns and opportunities . N Engl J Med. 337:1997;1360-1369.
2. Scheinman M.M. Atrial fibrillation and congestive heart failure the intersection of two common diseases . Circulation. 98:1998;941-942.
3. Alpert J.S. Atrial fibrillation a growth industry in the 21st century . Eur Heart J. 21:2000;1207-1208.
4. 2001 Heart and Stroke Statistical Update. 2000;American Heart Association, Dallas, Texas.
5. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA. 285:2001;2370-2375.
6. Feinberg W.M., Blackshear J.L., Laupacis A. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 155:1995;469-473.
7. Bureau of the Census Statistical Brief . Sixty-Five Plus in the United States. 1995;U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census, Washington, DC.
8. Census 2000. Profiles of General Demographic Characteristics. 2000 Census of Population and Housing-MinnesotaWashington, DC: U.S. Census Bureau; 2000.
9. Wolf P.A., Benjamin E.J., Belanger A.J., et al. Secular trends in the prevalence of atrial fibrillation the Framingham Study . Am Heart J. 131:1996;790-795.
10. Tsang T., Petty T., O'Fallon W., et al. The changing prevalence of atrial fibrillation in men and women of Rochester, Minnesota a population-based study, 1960-1989 . J Am Coll Cardiol. 39:(9 suppl B):2002;61B.
11. Vidaillet H., Granada J.F., Chyou P.H., et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 113:2002;365-370.
12. Stewart S., Hart C.L., Hole D.J., McMurray J.J.V. A population based study of the long-term risks associated with atrial fibrillation 20-year follow-up of the Renfrew/Paisley Study . Am J Med. 113:2002;000-0.
13. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death the Framingham Heart Study . Circulation. 98:1998;946-952.
14. Gajewski J., Singer R.B. Mortality in an insured population with atrial fibrillation. JAMA. 245:1981;1540-1544.
15. Krahn A.D., Manfreda J., Tate R.B., et al. The natural history of atrial fibrillation incidence, risk factors, and prognosis in the Manitoba Follow-Up Study . Am J Med. 98:1995;476-484.
16. Cairns J.A., Connolly S.J. Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation. 84:1991;469-481.
17. Simons L.A., McCallum J., Friedlander Y., Simons J. Risk factors for ischemic stroke. Dubbo Study of the Elderly. Stroke. 29:1998;1341-1346.
18. Whisnant J.P., Wiebers D.O., O'Fallon W.M., et al. A population-based model of risk factors for ischemic stroke Rochester, Minnesota . Neurology. 47:1996;1420-1428.
19. Wolf P.A., Dawber T.R., Thomas H.E. Jr, Kannel W.B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke the Framingham study . Neurology. 28:1978;973-977.
20. Wolf P., Abbott R., Kannel W. Atrial fibrillation as an independent risk factor for stroke. The Framingham Study. Stroke. 22:1991;983-988.
21. Lip G.Y.H. The prothrombotic state in atrial fibrillation new insights, more questions, and clear answers needed . Am Heart J. 140:2000;348-350.
22. Poli K., Tofler G., Larson M., et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation. 101:2000;264-269.
23. Lip G. Does atrial fibrillation confer a hypercoagulable state? Lancet. 346:1995;1313-1314.
24. Kumagai K., Fukunami M., Kitabatake A., et al. Increased cardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol. 16:1990;377-380.
25. Ott A., Breteler M.M., de Bruyne M.C., et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 28:1997;316-321.
26. Breteler M.M. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci. 903:2000;457-465.
27. Kilander L., Andren B., Nyman H., et al. Atrial fibrillation is an independent determinant of low cognitive function a cross-sectional study in elderly men . Stroke. 29:1998;1816-1820.
28. O'Connell J.E., Gray C.S., French J.M., Robertson I.H. Atrial fibrillation and cognitive function case-control study . J Neurol Neurosurg Psychiatry. 65:1998;386-389.
29. Sabatini T., Frisoni G.B., Barbisoni P., et al. Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc. 48:2000;387-390.
30. Scheinman M.M. Atrial fibrillation and congestive heart failure the intersection of two common diseases . Circulation. 98:1998;941-942.
31. Pozzoli M., Cioffi G., Traversi E., et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure a prospective study in 344 patients with baseline sinus rhythm . J Am Coll Cardiol. 32:1998;197-204.
32. Redfield M., Kay G., Jenkins L., et al. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 75:2000;790-795.
33. Stevenson W.G., Stevenson L.W. Atrial fibrillation in heart failure. N Engl J Med. 341:1999;910-911.
34. Shinbane J., Wood M., Jensen D., et al. Tachycardia-induced cardiomyopathy a review of animal models and clinical studies . J Am Coll Cardiol. 29:1997;709-715.
35. Tsang T.S.M., Gersh B.J., Appleton C.P., et al. Left ventricular diastolic dysfunction an important predictor of first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women . J Am Coll Cardiol. 39:(suppl A):2002;460A.
36. Wolf P.A., Mitchell J.B., Baker C.S., et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 158:1998;229-234.
37. Kim M., Conlon B., Ebinger M., et al. Clinical outcomes and costs associated with a first episode of uncomplicated atrial fibrillation presenting to the emergency room. Am J Cardiol. 88:2001;74-76.
38. Dell'Orfano J.T., Blaha C., Kramer K., et al. A prospective evaluation of patients with acute atrial fibrillation using a clinical pathway improves length of stay and reduces cost of care . Pacing Clin Electrophysiol. 23:2000;668.
39. Dell'Orfano J.T., Kramer R.K., Naccarelli G.V. Cost-effective strategies in the acute management of atrial fibrillation. Curr Opin Cardiol. 15:2000;23-28.
40. Chung M., Martin D., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation . Circulation. 104:2001;2886-2891.
41. Ross R. Atherosclerosis an inflammatory disease . N Engl J Med. 340:1999;115-126.
42. Tsang T., Barnes M., Bailey K., et al. Left atrial volume important risk marker of incident atrial fibrillation in 1655 older men and women . Mayo Clin Proc. 76:2001;467-475.
43. Jais P., Shah D.C., Takahashi A., et al. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 21:1998;2533-2538.
44. Brugada R., Tapscott T., Czernuszewicz G., et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 336:1997;905-911.
45. Yue L., Melnyk P., Gaspo R., et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res. 84:1999;776-784.
46. Lai L.P., Su M.J., Lin J.L., et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban - an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol. 33:1999;1231-1237.
47. Van Gelder I.C., Brundel B., Henning R.H., et al. Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 10:1999;552-560.
48. Van Wagoner D.R., Pond A.L., Lamorgese M., et al. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 85:1999;428-436.
49. Nattel S. The molecular and ionic specificity of antiarrhythmic drug actions. J Cardiovasc Electrophysiol. 10:1999;272-282.